Biomarker could predict pathologic response to chemotherapy among bladder cancer patients

Long-term survival data from the first prospective, randomized biomarker validation trial in patients with muscle-invasive bladder cancer being treated with cisplatin-based chemotherapy before surgery will be reported at the 2022 Genitourinary Cancers Symposium of the American Society of Clinical Oncology (GU ASCO) on February 18, 2022.

The results are from the S1314 clinical…

Continue Reading


News Source: https://www.news-medical.net/news/20220215/Biomarker-could-predict-pathologic-response-to-chemotherapy-among-bladder-cancer-patients.aspx

Leave a comment